Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

UK doctors embracing technology, but not for their patients, survey reveals

November 6, 2015 Medical Communications, Research and Development

A global online survey of doctors released by market research agency Cello Health Insight has indicated that although UK doctors …
News
Sanofi logo

Sanofi buys in new diabetes drug

November 6, 2015 Medical Communications, Research and Development, Sales and Marketing Lexicon Pharma, SGLT2, SGLT2 inhibitors, Sanofi, sotagliflozin

Sanofi has paid an initial $300 million for collaboration and license agreement to develop sotagliflozin, one of a newer class …
News
Olivier Brandicourt

Brandicourt sets out Sanofi’s long-term vision

November 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, olivier brandicourt, pharma strategy

Sanofi has pledged to plough the money saved from its business restructure into R&D investment, to bring 18 new products …
News
nsclc_merck_pfizer

Merck and Pfizer begin new Phase III avelumab trial in lung cancer

November 5, 2015 Medical Communications, Research and Development Merck, Pfizer, avelumab, lung cancer, non-small cell lung cancer

Merck and Pfizer have commenced an international Phase III study of the investigational cancer immunotherapy avelumab in patients with non-small …
News
Pascale Witz Sanofi

Sanofi and Hanmi partner to create long-acting diabetes treatments

November 5, 2015 Manufacturing and Production, Research and Development Korea, Sanofi, diabetes, hanmi

Sanofi and Hanmi Pharmaceutical have announced a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments. Korea’s …
News
President Obama

Obama government launches drug price crackdown

November 4, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, President Obama, US, affordability, market access

President Obama has launched an ‘Affordable Drug Pricing Task Force’, aimed at tackling the spiralling cost of certain prescription medications …
News
lradvanyi_2

Merck appoints Laszlo Radvanyi as head of global immuno-oncology research

November 4, 2015 Research and Development Laszlo Radvanyi, Merck

Dr Laszlo Radvanyi has joined Merck as senior vice president and head of research in immuno-oncology.  The Merck Group says …
Appointment
GSK logo

GSK plots return to growth with launch of 20 new drugs by 2020

November 4, 2015 Research and Development, Sales and Marketing GSK, Sir Andrew Witty, financial results, product pipeline

GSK has set out plans to boost its flagging performance with the launch of up to 20 new drugs by …
News
researchers examining test tube

Drugs later in development ‘winning the race to market’

November 4, 2015 Research and Development R&D, drug approval, drug development, market exclusivity

Nearly all later entrants to drug classes were in clinical testing or regulatory review before first-in-class approval, according to the …
News
Andrew Witty GSK

Pfizer approached GSK for takeover before Allergan

November 4, 2015 Research and Development, Sales and Marketing Allergan, GSK, Pfizer, financial results, product pipeline

Pfizer had a takeover approach rejected by fellow pharma giant GlaxoSmithKline, before turning its attentions to Allergan, it has emerged. …
News
BMS building

Bristol-Myers Squibb enters academic R&D tie-up

November 4, 2015 Research and Development BMS, Bristol-Myers Squibb, Cardioxy, John Hopkins, acquisition, immunooncology, job losses

Bristol-Myers Squibb and The Johns Hopkins University have entered into a collaboration agreement, as part of the pharma firm’s rare …
News
MRI obese overweight

Novo Nordisk forms academic partnership with Washington Uni

November 4, 2015 Research and Development Novo Nordisk, diabetes, obesity

Novo Nordisk has launched a new research collaboration with researchers at the University of Washington, to develop new drugs for …
News
Prof Paul Workman

Putting off-patent drugs back to work

November 4, 2015 Research and Development, Sales and Marketing Off-Patent Drugs Bill, Professor Paul Workman, The ICR, The ICR London, drug repurposing, patents

Six clinicians here at The Institute of Cancer Research, London, have joined colleagues from across the UK in writing to …
Feature
GSK building

GSK and Merck to study immunotherapy combo in solid tumours

November 3, 2015 Research and Development GSK, Merck, immunooncology, immunotherapy, keytruda, phase I

GSK and Merck will start a Phase I clinical trial in humans to evaluate GSK’s investigational cancer drugs with the …
News
paul_oliver_cfo_biocity

Pharma R&D hub BioCity appoints new CFO

November 3, 2015 Manufacturing and Production, Research and Development, Sales and Marketing BioCity, Paul Oliver

BioCity, the UK bioscience incubator, has appointed Paul Oliver as chief financial officer as it prepares to grow across its …
Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026